Immune checkpoint inhibitors plus chemotherapy in first-line endometrial cancer treatment: Still the era of microsatellites?
Mauro Francesco Pio MaioranoCarlo MessinaEvaristo MaielloGennaro CormioBrigida Anna MaioranoPublished in: BJOG : an international journal of obstetrics and gynaecology (2024)
Adding ICIs to chemotherapy significantly improves PFS in first-line endometrial cancer, regardless of MMR status.